期刊文献+

糖皮质激素治疗类风湿关节炎的初步临床分析 被引量:7

Clinical analysis on rheumatoid arthritis treated with glucocorticoids
下载PDF
导出
摘要 目的初步探讨糖皮质激素(glucocorticoids,GCs)在类风湿关节炎(rheumatoid arthritis,RA)中使用的利弊。方法随机调查53例RA患者使用GCs的情况(非激素组25例,激素组28例),详细记录GCs使用的剂量、时间,同时测定所有患者的临床及相关实验室指标,比较非激素组和激素组RA患者间上述指标的差异。结果两组患者间年龄、BM I、病程、性别构成以及是否使用改变病情抗风湿药物等基本情况比较显示,差异无统计学意义(P>0.05)。非激素组与激素组在关节压痛指数(21.92±15.52)vs(35.39±17.53)、关节肿胀指数(8.88±6.21)vs(12.61±6.66)、HAQ积分(0.83±0.69)vs(1.76±0.80)、患者评价(5.44±1.80)vs(6.61±1.50)、关节功能分级构成比(1∶13∶10∶1)vs(0∶5∶12∶11)、关节X线分期构成比(6∶14∶4∶1)vs(1∶12∶8∶7)及骨质疏松发生率(5/25vs13/28)的比较显示,差异有统计学意义(P<0.05)。服用激素的总量与关节压痛指数(r=0.308,P=0.025)、HAQ积分(r=0.549,P=0.0001)、患者评价(r=0.301,P=0.028)、双手平均握力(r=-0.337,P=0.014)和桡骨远端骨密度(r=-0.362,P=0.008)呈直线相关。结论不适当使用GCs治疗的RA患者关节压痛和肿胀数更多,HAQ积分更高,患者评价、关节功能和关节X线分期更差,骨质疏松的发生率亦更高;但每日3片左右的强的松使用1.5年对RA血压、血糖和血脂的影响并不大。 Objective To investigate the benefit and harm of glucocorticoids (GCs)treatment on patients with rheumatoid arthritis (RA). Methods Clinical data of 53 patients with RA were analyzed randomly. The dosage and duration of GCs were noted in details. All the clinical and laboratory factors were compared between group of GCs(n = 28 ), who were treated with GCs previously or currently, and group of non-GCs, who were treated with GCs never( n = 25 ). Results There were no significant differences in age, sex,index of avoir- dupois, duration of disease, ratio of patients who were treated with disease modifying anti-rheumatism drugs or not between group of GCs and non-GCs. Patients who were treated with GCs previously or currently had more worse of index of swollen or tenderness of joint, scores of HAQ, assessment of patients, function of joint, radiographic change of joint than those of patients who were treated with GCs never(P 〈0. 05). Patients in group of GCs also had higher rate of osteoporosis than those of patients in group of non-GCs ( 13/28 versus 5/25, P 〈 0. 05 ). There was a linear correlation between the cumulated dosages of GCs and index of tenderness of joint( r = 0. 308, P = 0. 025 ) , scores of HAQ ( r = 0. 549, P = 0. 0001 ), assessment of patients ( r = 0. 301, P = 0. 028 ) , average grip strength of two hands ( r = -0. 337, P = 0. 014) , bone mineral density of ultra-radio ( r = -0. 362, P = 0. 008 ). Conclusion Patients with RA who were treated with un-appropriate GCs had no clinical improvement, but had more ratio of osteoporosis. It was harmless for blood pressure, blood sugar, serum cholesterin and glyceride of patients with RA who treated with predison 15 mg per day for 1.5years.
出处 《中国实用医药》 2008年第24期16-18,共3页 China Practical Medicine
关键词 类风湿关节炎 糖皮质激素 骨质疏松 Rheumatoid arthritis Glucocorticoids Osteoporosis
  • 相关文献

参考文献10

  • 1[1]Saag KG,Criswell LA,Sems KM,et al.Low-dose corticosteroids in rheumatoid arthritis.A meta-analysis of their moderate-term effectiveness.Arthritis Rheum,1996,39 (11):1818 -1825. 被引量:1
  • 2[2]Van Everdingen AA,Jacobs JW,Siewertsz Van Reesema DR,et al.Low-dose prednisone therapy for patients with early active rheumatoid arthritis:clinical efficacy,disease-modifying properties,and side effects:a randomized,double-blind,placebo-controllod clinical trial.Ann Intern Med,2002,136 (1):1-12. 被引量:1
  • 3[4]Kirwan JR.The effect of glucocorticoids on joint destruction in rheumatoid arthritis.The arthritis and rheumatism council low-dose glucocorticoid study group.N Engl J Med,1995,333 (3):142-146. 被引量:1
  • 4[5]American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines.Guidelines for the management of rheumatoid arthritis:2002 Update.Arthritis Rheum,2002,46 (2):328-346. 被引量:1
  • 5类风湿关节炎诊治指南(草案)[J].中华风湿病学杂志,2003,7(4):250-254. 被引量:430
  • 6[7]De Bosscher K,Vanden Berghe W,Haegeman G.The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1:molecular mechanisms for gene repression.Endoer Rev,2003,24(4):488-522. 被引量:1
  • 7[8]Bijlsma JW,Boers M,Saag KG,et al.Glucocorticoids in the treatment of early and late Rheumatoid Arthritis.Ann Rheum.Dis,2003,62(11):1033-1037. 被引量:1
  • 8穆荣,栗占国.糖皮质激素在类风湿关节炎治疗中的应用[J].中华全科医师杂志,2005,4(3):143-145. 被引量:5
  • 9[10]Buttgerreit F,da Silva JA,Boers M,et al.Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens:current questions and tentative answers in rheumatology.Ann Rheum Dis,2002,61 (8):718-722. 被引量:1
  • 10[11]van Everdingen AA,Siewertsz Van Reesema DR,Jacobs JW,et al.Low-dosc glucccorticoids in early rheumatoid arthritis:discordant effects on bone mineral density and fractures Clin Exp Rheumatol,2003,21 (2):155-160. 被引量:1

二级参考文献19

  • 1Saag KG,Criswell LA,Sems KM,et al. Low-dose corticosteroids in rheumatoid arthritis. A meta-analysis of their moderate-term effectiveness. Arthritis Rheum,1996,39:1818-1825. 被引量:1
  • 2van Everdingen AA,Jacobs JW,Siewertsz Van Reesema DR,et al. Low-dose prednisone therapy for patients with early active rheumatoid arthritis:clinical efficacy,disease-modifying properties,and side effects:a randomized,double-blind,placebo-controlled clinical trial. Ann Intern Med,2002,136:1-12. 被引量:1
  • 3American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum,2002,46:328-346. 被引量:1
  • 4Hansen M,Podenphant J,Florescu A,et al. A randomised trial of differentiated prednisolone treatment in active rheumatoid arthritis:clinical benefits and skeletal side effects. Ann Rheum Dis,1999,58:713-718. 被引量:1
  • 5van Everdingen AA,Siewertsz Van Reesema DR,Jacobs JW,et al. The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapies. Arthritis Rheum,2004,51:233-238. 被引量:1
  • 6Bijlsma JW,Boers M,Saag KG,et al. Glucocorticoids in the treatment of early and late RA. Ann Rheum Dis,2003,62:1033-1037. 被引量:1
  • 7Boers M,Nurmohamed MT,Doelman CJ,et al. Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis,2003,62: 842-845. 被引量:1
  • 8van Everdingen AA,Siewertsz Van Reesema DR,Jacobs JW,et al. Low-dose glucocorticoids in early rheumatoid arthritis:discordant effects on bone mineral density and fractures? Clin Exp Rheumatol,2003,21: 155-160. 被引量:1
  • 9American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum,2001,44:1496-1503. 被引量:1
  • 10Piper JM,Ray WA,Daugherty JR,et al. Corticosteroid use and peptic ulcer disease:role of nonsteroidal anti-inflammatory drugs. Ann Intern Med,1991,114:735-740. 被引量:1

共引文献433

同被引文献60

引证文献7

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部